Skip to main content
SpringerLink
Log in

Adalimumab/etanercept

Exacerbation of interstitial lung disease: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Schuller A, Coudurier M, Lega J-C, Khouatra C, Cottin V, Cordier J-F.Interstitial lung disease and anti-TNF-alpha therapy in rheumatoid arthritis: Two different patterns?. Revue des Maladies Respiratoires 27: 232-237, Jan 2010. Available from: URL: http://dx.doi.org/10.1016/j.rmr.2010.01.011 - France

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab/etanercept. React. Wkly. 1319, 8 (2010). https://doi.org/10.2165/00128415-201013190-00024

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013190-00024

Keywords

Search

Navigation